000 01098 a2200289 4500
005 20250516184811.0
264 0 _c20141105
008 201411s 0 0 eng d
022 _a1938-0682
024 7 _a10.1016/j.clgc.2013.04.035
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan der Veldt, Astrid A M
245 0 0 _aDoes drug accumulation in bone explain the efficacy and toxicity of docetaxel in prostate cancer?
_h[electronic resource]
260 _bClinical genitourinary cancer
_cApr 2014
300 _ae63-4 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeutropenia
_xchemically induced
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aTaxoids
_xadministration & dosage
700 1 _aSmit, Egbert F
700 1 _aLammertsma, Adriaan A
773 0 _tClinical genitourinary cancer
_gvol. 12
_gno. 2
_gp. e63-4
856 4 0 _uhttps://doi.org/10.1016/j.clgc.2013.04.035
_zAvailable from publisher's website
999 _c23360850
_d23360850